Elanco Animal Health Stock News

LONDON, Jan. 12, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Company''s research report on the animal medicine market, the production of medicated feed additives is a major trend in the animal medicine market. Medicated feed additives in general help maintain animal health and promote growth and feed efficiency. They include vitamins, amino acids, fatty acids, pharmaceuticals, minerals, growth hormones and fungus. Animal medicines manufacturers have started increasingly producing medicated feed additives to improve efficiencies of production. For instance, in January 2020, Kemin Industries, a US-based ingredient manufacturer, launched VANNIX C4, a novel phytogenic feed additive for poultry gut health. VANNIX C4 is a probiotic feed additive formulation of gut-health-fortifying ingredients to minimize the impact of enteric challenges on poultry performance. The global animal medicine market size grew from $32.7 billion in 2020 to $37.88 billion in 2021 at a compound annual growth rate (CAGR) of 15.8% .

Elanco Animal Health Inc (ELAN) shares closed today at 0.7% above its 52 week low of $26.86, giving the company a market cap of $12B. The stock is currently down 4.7% year-to-date, down 13.0% over the past 12 months, and down 24.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 2.3% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 8.4% The company's stock price performance over the past 12 months beats the peer average by -32.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Elanco Animal Health Inc (ELAN) shares closed 0.3% lower than its previous 52 week low, giving the company a market cap of $13B. The stock is currently down 1.7% year-to-date, down 8.8% over the past 12 months, and down 22.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 12.6% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -51.3% The company's stock price performance over the past 12 months beats the peer average by -53.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Strs Ohio trimmed its stake in Elanco Animal Health Incorporated (NYSE:ELAN) by 20.2% during the third quarter, HoldingsChannel reports. The institutional investor owned 18,316 shares of the companys stock after selling 4,625 shares during the period. Strs Ohios holdings in Elanco Animal Health were worth $584,000 as of its most recent SEC filing. A number []

Elanco Animal Health Incorporated (NYSE:ELAN) at last check was buoying at $28.53 on Thursday, December 23 with a rise of 0.67% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $28.34 and 5Y monthly beta was reading 0.83 with its price kept Elanco Animal Health Incorporated (ELAN): Worth A Little Bit At $28.53 Read More »

The Latest report about the Animal Medicine market provides a detailed evaluation of the business vertical in question, alongside a brief overview of the industry segments. An exceptionally workable estimation of the present industry scenario has been delivered in the

Banque Cantonale Vaudoise increased its position in shares of Elanco Animal Health Incorporated (NYSE:ELAN) by 223.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 24,286 shares of the companys stock after acquiring an additional 16,786 shares during the quarter. Banque Cantonale Vaudoises []

Janney Montgomery Scott LLC lifted its position in shares of Elanco Animal Health Incorporated (NYSE:ELAN) by 1.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 214,432 shares of the companys stock after acquiring an additional 2,965 shares during the []

Mayflower Financial Advisors LLC bought a new position in Elanco Animal Health Incorporated (NYSE:ELAN) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 7,480 shares of the companys stock, valued at approximately $244,000. A number of other institutional investors and hedge funds have also recently []

Equities analysts forecast that Elanco Animal Health Incorporated (NYSE:ELAN) will announce sales of $1.10 billion for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Elanco Animal Healths earnings. The lowest sales estimate is $1.09 billion and the highest is $1.12 billion. Elanco Animal Health posted sales of $1.14 billion in []

Vaughan Nelson Investment Management L.P. increased its holdings in Elanco Animal Health Incorporated (NYSE:ELAN) by 16.5% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,858,121 shares of the companys stock after purchasing an additional 405,737 shares during the period. Elanco Animal Health makes []

Major animal drugs market players include Elanco Animal Health, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals Ltd, Virbac S.A., and Merck Animal Health. Major animal drugs market players include Elanco Animal Health, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals Ltd, Virbac S.A., and Merck Animal Health.

Analysts predict that Elanco Animal Health Incorporated (NYSE:ELAN) will announce earnings of $0.17 per share for the current quarter, according to Zacks. Four analysts have made estimates for Elanco Animal Healths earnings. The highest EPS estimate is $0.19 and the lowest is $0.16. Elanco Animal Health posted earnings per share of $0.12 in the same []

Elanco Animal Health (NYSE:ELAN)s stock had its hold rating reiterated by analysts at Barclays in a research report issued to clients and investors on Wednesday, PriceTargets.com reports. Other equities analysts have also recently issued research reports about the stock. Stifel Nicolaus cut shares of Elanco Animal Health from a buy rating to a hold rating []